New Study Shows Belzutifan and Pembrolizumab Combo Extends Cancer-Free Survival in High-Risk Kidney Cancer Patients After Surgery
In a groundbreaking advancement for kidney cancer treatment, the recent phase 3 LITESPARK-022 clinical trial has demonstrated that combining belzutifan, ...
